[Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine]
- PMID: 2451185
[Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine]
Abstract
The period of survival in the group of 36 boys and 18 girls with SSPE, as well as the condition of 13 living persons were examined. 30 children were treated with isoprinosine. A 3 years-long period of survival was significantly more frequent in the group of 18 children with long-term therapy by isoprinosine in comparison to 24 children without isoprinosine administration. The best results were observed in children with subacute course of the illness and many epileptic seizures. The 13 living persons are strongly damaged. One girl is decerebrated and 5 patients are completely helpless. The indications to isoprinosine therapy in SSPE are discussed.
Similar articles
-
The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).Ann Neurol. 1977 Feb;1(2):183-4. doi: 10.1002/ana.410010214. Ann Neurol. 1977. PMID: 70187 No abstract available.
-
Isoprinosine therapy and SSPE.Ann Neurol. 1980 Dec;8(6):642. doi: 10.1002/ana.410080620. Ann Neurol. 1980. PMID: 6163393 Clinical Trial. No abstract available.
-
Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.Ann Neurol. 1980 Feb;7(2):185-8. doi: 10.1002/ana.410070216. Ann Neurol. 1980. PMID: 6154441
-
Treatment of subacute sclerosing panencephalitis: an overview.Drug Intell Clin Pharm. 1984 May;18(5):375-81. doi: 10.1177/106002808401800503. Drug Intell Clin Pharm. 1984. PMID: 6202474 Review.
-
Subacute sclerosing panencephalitis.J Neurol. 2008 Dec;255(12):1861-71. doi: 10.1007/s00415-008-0032-6. Epub 2008 Oct 14. J Neurol. 2008. PMID: 18846316 Review.